Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Observational × HER2-positive Metastatic Breast Cancer × Clear all

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 486 Neoplasms 408 Lung Neoplasms 265 Colorectal Neoplasms 256 Carcinoma, Non-Small-Cell Lung 190 Stomach Neoplasms 183 Carcinoma, Hepatocellular 181 Prostatic Neoplasms 171 Pancreatic Neoplasms 131 Ovarian Neoplasms 118 Colonic Neoplasms 107 Uterine Cervical Neoplasms 106 Rectal Neoplasms 96 Neoplasm Metastasis 88 Urinary Bladder Neoplasms 87 Head and Neck Neoplasms 70 Esophageal Neoplasms 70 Endometrial Neoplasms 68 Precursor Cell Lymphoblastic Leukemia-Lymphoma 67 Leukemia, Myeloid, Acute 66 Disease 62 Brain Neoplasms 62 Recurrence 60 Melanoma 57 Lymphoma 52 Multiple Myeloma 51 Glioma 51 Liver Neoplasms 50 Polycystic Ovary Syndrome 49 Squamous Cell Carcinoma of Head and Neck 43

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05188495 2022-01-12

HELP

Peking University Cancer Hospital & Institute

HER2-positive Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡